Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, the iShares S&P Global Healthcare
With that in mind, let's take a closer look at iShares S&P Global Healthcare and see what CAPS investors are saying about the ETF right now.
iShares S&P Global Healthcare facts
|Total Assets||$513.6 million|
|Investment Approach||Seeks investment results that correspond to the S&P Global 1200 Healthcare Sector Index, which includes health-care providers, biotech companies, and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.|
|1-Year / 3-Year / 5-Year Annual Returns||8.6% / 12.7% / 1.1%|
|Top Holdings with High CAPS Rating (4 or 5 Stars) and Portfolio Weight||
Johnson & Johnson
iShares Nasdaq Biotechnology
Vanguard Health Care
Sources: Morningstar and Motley Fool CAPS.
On CAPS, 97% of the 67 members who have rated iShares S&P Global Healthcare believe the ETF will outperform the S&P 500 going forward. These bulls include All-Star jaschajabes, who is ranked in the top 10% of our community, and GKuhfeldt.
Having gotten on board a few years ago, jaschajabes succinctly summed up the opportunity: "[L]ife expectancy rises so [health care costs] do as well. I see profits for the long haul here."
iShares S&P Global Healthcare, in particular, sports an annual turnover ratio of just 6%. That's lower than that of other health ETFs like iShares Nasdaq Biotech (13%) and Vanguard Health Care (9%).
CAPS member GKuhfeldt expands on the outperform argument:
The tail end of the Baby Boomers will be reaching retirement in the next 10-15 years. That combined with the low price as a result of this economy means over the long term this ETF can only go up. People will always need health care. Additionally, this is a GLOBAL Healthcare ETF. That gives it a more diverse base to provide for a more defensive long position.
What do you think about iShares S&P Global Healthcare, or any other ETF for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional ETFs is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!
Interested in another easy way to track iShares S&P Global Healthcare? Add it to your watchlist.
Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Fool owns shares of Johnson & Johnson. Motley Fool newsletter services have recommended buying shares of Johnson & Johnson, Pfizer, and Novartis, as well as creating a diagonal call position in Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days.